The Valley Desk

NCT03909165 · Interventional trial

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Overall registry status Completed

Phase 4

Conditions Neuromuscular Blockade

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov